Description:
Xefo 8 mg Vial is a solution for intravenous administration used to manage pain and inflammation in various clinical settings. It is commonly employed for postoperative pain, acute inflammation, and other conditions requiring strong analgesic and anti-inflammatory effects. The vial contains a precise concentration of the active ingredient, providing effective and controlled relief from symptoms.
Ingredients:
- Active Ingredient: Lornoxicam (8 mg per vial)
- Inactive Ingredients: [List any solvents, stabilizers, or other relevant components in the formulation]
Usage Instructions:
- Dosage: [Specify the recommended dosage, e.g., 8 mg]
- Frequency: [e.g., Administer every 8 hours, or as prescribed by a healthcare provider]
- Special Considerations: [e.g., Administer via slow intravenous injection or infusion, follow specific administration guidelines to avoid adverse effects]
Benefits:
• Provides rapid and effective pain relief
• Reduces inflammation associated with various conditions
• Useful in postoperative settings and acute inflammatory conditions
• Offers precise dosing for controlled pain management
Precautions:
• Not suitable for patients with a history of gastrointestinal bleeding or severe renal impairment
• Use with caution in patients with cardiovascular disease or those on anticoagulant therapy
• Possible side effects include dizziness, gastrointestinal discomfort, or headache
• Consult a healthcare provider if pregnant, planning to become pregnant, or breastfeeding
Storage Instructions:
• Store at room temperature (15-25°C)
• Protect from light and keep in a dry place
• Do not use if the solution is discolored or contains particles
• Keep out of reach of children
Manufacturer: Jazeera Pharmaceutical Industries (JPI)
